Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

RPL22 is a tumor suppressor in MSI-high cancers and a splicing regulator of MDM4

Cell Reports(2024)10.1016/j.celrep.2024.114622Source: DataRank Database

RPL22 is a tumor suppressor in MSI-high cancers and a splicing regulator of MDM4 is a research paper published in Cell Reports (2024). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

geo gen cellosaurus refseq uniprot doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.29)OA: goldTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (6)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Kevin Hu ORCID,Lisa Fish ORCID,Yih-An Chen,Paul Allegakoen,Julia H. Pham

Live enrichment

PubMed:39146182 PMC:PMC12035866 OpenAlex:https://openalex.org/W4401564780

NCI NIH HHS

Grant: R01 CA244634

NCI NIH HHS

Grant: R01 CA248920

NCI NIH HHS

Grant: U19 CA214253

CSRD VA

Grant: I01 CX002444

NCI NIH HHS

Grant: P20 CA233255

FWCI

3.29

Citation Percentile

0.9%

Influential Citations

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2211124724009720/pdf

GOLDhttps://doi.org/10.1016/j.celrep.2024.114622

publisherhttp://www.cell.com/article/S2211124724009720/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124724009720?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124724009720?httpAccept=text/plain

Fields of Study

RNA Research and SplicingCancer-related Molecular PathwaysUbiquitin and proteasome pathwaysMedicineBiology

MeSH Terms

AnimalsExonsHumansImidazolesNeoplasmsNuclear ProteinsPiperazinesProto-Oncogene ProteinsRibosomal ProteinsGene Expression Regulation, NeoplasticTumor Suppressor Protein p53Alternative SplicingCell Cycle ProteinsCell Line, TumorCell ProliferationMice

Keywords

RegulatorSuppressorRNA splicingCancer researchBiologyGeneticsCancerGeneRNAp53Alternative splicingTumor suppressorMdm4Ribosomal ProteinsRpl22Msi-hCp: Molecular BiologyCp: CancerMdm4 Exon 6 InclusionRpl22 P.k15fsMicrosattelite Instability-high

Sustainable Development Goals

SDG 0: Good health and well-being